Myocardial Infarction Completed Phase 4 Trials for Ticagrelor (DB08816)

Back to Myocardial Infarction

Also known as: Suspected myocardial infarction (MI) / Myocardial Infarct / MI / Myocardial Infarctions / Heart Attacks / Cardiac Infarct / Heart Attack / Myocardial Infarction (MI) / Cardiovascular Stroke / Stroke, Cardiovascular / Myocardial infarction (disorder) / Acute myocardial infarction / Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction / Attack heart (NOS) / Infarct myocardial / Right ventricular infarction / Attack coronary / Infarction of heart / Cardiac infarction, NOS / Attack - heart / Myocardial infarction, NOS / MI - myocardial infarction / Cardiac infarction / Heart attack, NOS / Infarction of heart, NOS / Myocardial infarction (& [acute]) or coronary thrombosis / Coronary artery thrombosis / Coronary artery thrombosis (disorder) / Thrombosis coronary / Coronary thrombosis / Occlusive coronary artery thrombus / Thrombosis - coronary / CT - Coronary thrombosis / (Myocardial infarction (& [acute] or [silent] or [cardiac rupture following])) or (coronary thrombosis)

Indication	Status	Phase
DBCOND0027900 (Myocardial Infarction)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02376283	P3AMI Antiplatelet Trial	Treatment	Clopidogrel (DB00758) Prasugrel (DB06209) Ticagrelor (DB08816)
NCT02733341	The Effect of IV Cangrelor and Oral Ticagrelor Study	Treatment	Cangrelor (DB06441) Ticagrelor (DB08816)
NCT02402400	Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study	Treatment	Ticagrelor (DB08816)
NCT02406248	Brilinta Taiwan Post Approval Safety Study	Treatment	Ticagrelor (DB08816)
NCT02224274	Antiplatelet Therapy After Cardiac Arrest	Treatment	Clopidogrel (DB00758) Ticagrelor (DB08816)
NCT04057300	Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes	Treatment	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758) Ticagrelor (DB08816)
NCT05380063	Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting	Treatment	Acetylsalicylic acid (DB00945) Ticagrelor (DB08816)
NCT03161678	CES1 Crossover Trial of Clopidogrel and Ticagrelor	Basic Science	Clopidogrel (DB00758) Ticagrelor (DB08816)
NCT02545933	Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor	Treatment	Acetylsalicylic acid (DB00945) Prasugrel (DB06209) Ticagrelor (DB08816) Vorapaxar (DB09030)
NCT02931045	Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction	Basic Science	Clopidogrel (DB00758) Ticagrelor (DB08816)
NCT01805570	Rapid Activity of Platelet Inhibitor Drugs Study 2	Treatment	Prasugrel (DB06209) Ticagrelor (DB08816)
NCT02663713	A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction	Treatment	Clopidogrel (DB00758) Ticagrelor (DB08816)
NCT03387826	Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction	Treatment	Prasugrel (DB06209) Ticagrelor (DB08816)
NCT02808767	Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction	Treatment	Prasugrel (DB06209) Ticagrelor (DB08816)
NCT01347580	A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)	Treatment	Ticagrelor (DB08816)